Definium Therapeutics grants options for 269,800 shares to 10 new employees
DFTX•Definium Therapeutics granted options to purchase 269,800 common shares to 10 newly hired non-executive employees. The grants vest over four years, subject to continued employment.
1. Option grants
The options were approved November 6, 2026, under the 2026 Inducement Plan and took effect November 9. Twenty-five percent vest on the first grant anniversary; the remaining 75% vest in substantially equal monthly increments over the next three years, subject to each employee's continued employment.
